Chlortalidone

BRAND NAMES

• Hygroton 

• Thalitone 

• Chlortalidone Sandoz (generic versions often carry the manufacturer’s name)

MECHANISM OF ACTION 

Chlortalidone is a thiazide-like diuretic that works by inhibiting the sodium-chloride symporter in the distal convoluted tubules of the kidneys. This reduces sodium and water reabsorption, increasing urine output, lowering blood volume, and decreasing blood pressure. Over time, it also promotes vasodilation, contributing to its antihypertensive effect

PHARMACOKINETICS

Absorption

Chlortalidone is well absorbed orally, with a bioavailability of about 60–80%. It reaches peak plasma concentrations within 2–6 hours after ingestion. Its absorption is not significantly affected by food, making it convenient for once-daily dosing.

Distribution

Chlortalidone has a volume of distribution of about 0.5–1 L/kgand is 50–60% bound to plasma proteins. It distributes mainly in the extracellular fluid, reaching the kidneys where it exerts its diuretic and antihypertensive effects.

Metabolism

Chlortalidone is minimally metabolized in the liver. Most of the drug remains unchanged and is excreted by the kidneys, which makes its pharmacologic activity primarily dependent on renal elimination rather than metabolic transformation.

Excretion

Chlortalidone is primarily excreted unchanged by the kidneys. A small amount may be eliminated in the feces. Its renal clearance contributes directly to its diuretic effect, and the drug has a long half-life of 40–60 hours, allowing once-daily dosing.

PHARMACODYNAMICS

Chlortalidone lowers blood pressure by inhibiting sodium and chloride reabsorption in the kidneys, causing increased urine output and reduced blood volume. Over time, it also dilates blood vessels, enhancing its antihypertensive effect.

ADMINISTRATION

It is taken orally once daily, usually in the morning, with or without food. Regular monitoring of blood pressure and electrolytes is required.

DOSAGE AND STRENGTH`

 Hypertension: Usually 12.5–25 mg once daily, can be increased to 50 mg if needed.

• Edema (heart failure, kidney disease): Typically 25–100 mg once daily, depending on severity.

• Administration: Oral, preferably in the morning to avoid nighttime urination.

DRUG INTERACTIONS

• Other antihypertensives – may enhance blood pressure-lowering effects 

• Lithium – risk of lithium toxicity due to reduced renal clearance 

• Digoxin – low potassium from chlortalidone can increase digoxin toxicity 

• NSAIDs – may reduce diuretic and antihypertensive effect 

• Corticosteroids or amphotericin B – increased risk of electrolyte disturbances

FOOD INTERACTIONS

Chlortalidone’s absorption is not significantly affected by food, so it can be taken with or without meals. However, a high-sodium diet may reduce its effectiveness, while foods rich in potassium (like bananas, oranges, spinach) can help prevent low potassium levels caused by the drug.

CONTRAINDICATIONS

Chlortalidone is contraindicated in patients with severe kidney impairment, anuria, hypersensitivity to sulfonamides, severe electrolyte imbalances, hypercalcemia, or advanced liver disease. Caution is advised in pregnancy, diabetes, and gout.

SIDE EFFECTS

• Dizziness, headache, or lightheadedness 

• Increased urination (diuresis) 

• Electrolyte imbalances: low potassium (hypokalemia), low sodium (hyponatremia), high calcium (hypercalcemia) 

• Fatigue or weakness 

• Gout or elevated uric acid levels 

• Rare: rash, photosensitivity, or kidney dysfunction

OVER DOSE

• Severe electrolyte imbalances (hypokalemia, hyponatremia) 

• Dehydration and low blood pressure 

• Dizziness, weakness, or fainting

TOXICITY

Chlortalidone toxicity occurs from excessive diuresis and electrolyte imbalances, leading to dizziness, weakness, low blood pressure, arrhythmias, and kidney problems. Treatment involves correcting electrolytes, restoring fluids, and close monitoring.